Fig. 5From: hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling PathwayExpression of Wnt3a, FZD1, and FZD3 in HCC cell linesBack to article page